A role for domain I of the hepatitis C virus NS5A protein in virus assembly

Journal article

Interferon regulatory factor 9 (IRF9) is an integral transcription factor in mediating the type I interferon antiviral response, as part of the interferon-stimulated gene factor 3. However, the role of IRF9 in many important non-communicable diseases has just begun to emerge. The duality of IRF9’s role in conferring protection but at the same time exacerbates diseases is certainly puzzling. The regulation of IRF9 during these conditions is not well understood. The high homology of IRF9 DNA-binding domain to other IRFs, as well as the recently resolved IRF9 IRF-associated domain structure can provide the necessary insights for progressive inroads on understanding the regulatory mechanism of IRF9. This review sought to outline the structural basis of IRF9 that guides its regulation and interaction in antiviral immunity and other diseases

Authors: Yin, C; Goonawardane, N; Stewart, H; Harris, M

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Public Library of Science
• Journal: PLoS Pathogens
• Volume: 14
• Issue: 1
• Pages: e1006834-e1006834
• Publication date: 2018-01-19
• DOI: 10.1371/journal.ppat.1006834
• EISSN: 1553-7374
• ISSN: 1553-7366
• Language: English
• Keywords: RNA virus; Mutant; NS2-3 protease; NS5A; Gene; Viral replication; Virology; Cell biology; Hepacivirus; Genome; Replicon; Hepatitis C virus; Protein domain; Virus; RNA; Genetics; Lipid droplet; Biology